Egberg N - Search Results

1

Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.

Mobarrez F, He S, Bröijersen A, Wiklund B, Antovic A, Antovic J, Egberg N, Jörneskog G, Wallén H. Mobarrez F, et al. Among authors: egberg n. Thromb Haemost. 2011 Aug;106(2):344-52. doi: 10.1160/TH10-12-0810. Epub 2011 May 26. Thromb Haemost. 2011. PMID: 21614411 Clinical Trial.

2

A multicolor flow cytometric assay for measurement of platelet-derived microparticles.

Mobarrez F, Antovic J, Egberg N, Hansson M, Jörneskog G, Hultenby K, Wallén H. Mobarrez F, et al. Among authors: egberg n. Thromb Res. 2010 Mar;125(3):e110-6. doi: 10.1016/j.thromres.2009.10.006. Epub 2009 Nov 24. Thromb Res. 2010. PMID: 19939440

3

A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma.

He S, Zhu K, Skeppholm M, Vedin J, Svensson J, Egberg N, Blombäck M, Wallen H. He S, et al. Among authors: egberg n. Thromb Haemost. 2007 Oct;98(4):871-82. Thromb Haemost. 2007. PMID: 17938814

4

Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study.

Mobarrez F, Egberg N, Antovic J, Bröijersen A, Jörneskog G, Wallén H. Mobarrez F, et al. Among authors: egberg n. Thromb Res. 2012 Jan;129(1):95-7. doi: 10.1016/j.thromres.2011.09.027. Epub 2011 Oct 27. Thromb Res. 2012. PMID: 22035651 Clinical Trial. No abstract available.

5

Are results of fibrinogen measurements transferable?

Kallner A, Egberg N, Yu A, Merzoug-Djilali R, Blomberg I, Jörneskog G, Blombäck M. Kallner A, et al. Among authors: egberg n. Clin Chem Lab Med. 2003 Jun;41(6):804-8. doi: 10.1515/CCLM.2003.122. Clin Chem Lab Med. 2003. PMID: 12880145

6

Altered properties of the fibrin gel structure in patients with IDDM.

Jörneskog G, Egberg N, Fagrell B, Fatah K, Hessel B, Johnsson H, Brismar K, Blombäck M. Jörneskog G, et al. Among authors: egberg n. Diabetologia. 1996 Dec;39(12):1519-23. doi: 10.1007/s001250050607. Diabetologia. 1996. PMID: 8960835

7

Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro.

Larsson PT, Wallén NH, Martinsson A, Egberg N, Hjemdahl P. Larsson PT, et al. Among authors: egberg n. Thromb Haemost. 1992 Dec 7;68(6):687-93. Thromb Haemost. 1992. PMID: 1337630

8

The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.

Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H. Lindmarker P, et al. Among authors: egberg n. Thromb Haemost. 1999 May;81(5):684-9. Thromb Haemost. 1999. PMID: 10365737

9

Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C.

Linder R, Blombäck M, Egberg N, Grip L. Linder R, et al. Among authors: egberg n. Thromb Res. 1999 Jul 15;95(2):117-25. doi: 10.1016/s0049-3848(99)00029-8. Thromb Res. 1999. PMID: 10418800

10

Coagulation inhibition capacities of low-molecular mass and unfractionated heparin, as determined by thrombin generation.

Elgue G, Sanchez J, Egberg N, Olsson P. Elgue G, et al. Among authors: egberg n. Thromb Res. 1994 Sep 1;75(5):539-49. doi: 10.1016/0049-3848(94)90228-3. Thromb Res. 1994. PMID: 7992254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters